Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
CA 2512502 A1 · Owner: Bayer Healthcare Ag · Inventors: Woltering, Michael; Dittrich-Wengenroth, Elke; Heckroth, Heike
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to novel indole-phenylsulfonamide derivatives to , methods for the production thereof and to their use in medicaments, particularly as potent PPAR-delta activating compounds for the prevention , and/or treatment of cardiovascular diseases particularly dyslipidemias and , coronary heart diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 24, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.